Altimmune, Inc. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Agency Agreements (4 contracts)
- Development Agreements (5)
- Indemnification Agreements (1)
- Termination Agreements (1)
- Voting Agreements (2)
- Amendment No. 8 Contract Award issued by the Biomedical Advanced Research and Development Authority of the United Sates Department of Health and Human Services, dated September... (Filed With SEC on November 9, 2021)
- Amendment No. 7 Contract Award issued by the Biomedical Advanced Research and Development Authority of the United Sates Department of Health and Human Services, dated June 29, 2021 (Filed With SEC on August 10, 2021)
- Amendment No. 6 to Contract Award issued by the Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services, dated December... (Filed With SEC on February 25, 2021)
- Amendment No. 5 to Contract Award issued by Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services, dated August 20,... (Filed With SEC on November 13, 2019)
- Placement Agency Agreement among Altimmune, Inc. and Roth Capital Partners, LLC (Filed With SEC on March 11, 2019)
- Placement Agency Agreement among Altimmune, Inc. and Roth Capital Partners, LLC (Filed With SEC on October 9, 2018)
- Amendment No. 4 to Contract Award issued by the Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services, dated... (Filed With SEC on September 26, 2018)
- Placement Agency Agreement by and between Altimmune, Inc. and Roth Capital Partners, LLC (Filed With SEC on September 25, 2018)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on August 14, 2017)
- FORM OF Parent VOTING AGREEMENT (Filed With SEC on January 19, 2017)
- TERMINATION AGREEMENT (Filed With SEC on December 2, 2013)
- PHARMATHENE,INC. VOTING AND LOCK-UP AGREEMENT (Filed With SEC on August 1, 2013)
- PHARMATHENE, INC. PLACEMENT AGENCY AGREEMENT (Filed With SEC on June 10, 2011)
